Teachers Retirement System of The State of Kentucky Sells 17,430 Shares of Tempus AI, Inc. $TEM

Teachers Retirement System of The State of Kentucky reduced its position in Tempus AI, Inc. (NASDAQ:TEM – Free Report) by 13.9% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 108,217 shares of the company’s stock after selling 17,430 shares during the period. Teachers Retirement System of The State of Kentucky’s holdings in Tempus AI were worth $8,863,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. HighTower Advisors LLC lifted its stake in shares of Tempus AI by 23.6% during the third quarter. HighTower Advisors LLC now owns 16,772 shares of the company’s stock valued at $1,374,000 after acquiring an additional 3,201 shares during the period. Royce & Associates LP bought a new position in Tempus AI in the third quarter valued at about $9,220,000. Ground Swell Capital LLC acquired a new stake in Tempus AI in the third quarter worth about $542,000. Maryland State Retirement & Pension System increased its position in Tempus AI by 35.5% in the third quarter. Maryland State Retirement & Pension System now owns 6,649 shares of the company’s stock worth $545,000 after purchasing an additional 1,743 shares during the period. Finally, Jefferies Financial Group Inc. bought a new stake in Tempus AI during the 3rd quarter worth about $1,234,000. 24.22% of the stock is owned by institutional investors and hedge funds.

Tempus AI Trading Down 2.1%

NASDAQ TEM opened at $63.43 on Wednesday. The stock has a 50-day simple moving average of $72.82 and a 200 day simple moving average of $57.54. The company has a market capitalization of $11.57 billion, a PE ratio of -59.84 and a beta of 3.61. The company has a current ratio of 2.61, a quick ratio of 2.48 and a debt-to-equity ratio of 2.70. Tempus AI, Inc. has a 12 month low of $40.77 and a 12 month high of $89.09.

Tempus AI (NASDAQ:TEM – Get Free Report) last released its earnings results on Monday, November 2nd. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of ($0.09) by $0.16. Tempus AI had a negative return on equity of 47.00% and a negative net margin of 12.54%. The firm had revenue of $411.54 million for the quarter, compared to analyst estimates of $409.39 million. During the same quarter in the prior year, the firm posted ($0.46) earnings per share. The company’s quarterly revenue was up 23.1% on a year-over-year basis. Research analysts forecast that Tempus AI, Inc. will post -1.20 EPS for the current year.

Wall Street Analysts Forecast Growth

TEM has been the topic of a number of research reports. Raymond James Financial set a $80.00 target price on shares of Tempus AI in a research report on Wednesday, September 2nd. The Goldman Sachs Group assumed coverage on shares of Tempus AI in a research report on Monday, September 21st. They set a “neutral” rating and a $75.00 price target for the company. Guggenheim boosted their price target on shares of Tempus AI from $65.00 to $92.00 and gave the stock a “buy” rating in a research note on Thursday, October 1st. JPMorgan Chase & Co. raised their price objective on shares of Tempus AI from $45.00 to $70.00 and gave the company a “neutral” rating in a research note on Wednesday, October 14th. Finally, Cantor Fitzgerald lifted their target price on shares of Tempus AI from $80.00 to $92.00 and gave the stock an “overweight” rating in a report on Tuesday, November 3rd. Eleven research analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $79.37.

View Our Latest Report on Tempus AI

Insider Buying and Selling

In other news, CEO Ryan Fukushima sold 700 shares of the company’s stock in a transaction dated Wednesday, September 16th. The stock was sold at an average price of $70.00, for a total value of $49,000.00. Following the completion of the sale, the chief executive officer directly owned 15,874 shares of the company’s stock, valued at $1,111,180. This represents a 4.22% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Eric Lefkofsky sold 250,000 shares of the stock in a transaction that occurred on Tuesday, October 27th. The shares were sold at an average price of $70.36, for a total transaction of $17,590,000.00. Following the completion of the sale, the chief executive officer owned 50,000 shares in the company, valued at $3,518,000. This represents a 83.33% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 978,449 shares of company stock worth $72,226,961 over the last quarter. Insiders own 24.26% of the company’s stock.

About Tempus AI

(Free Report)

Tempus AI is a technology company focused on applying data and artificial intelligence to healthcare, with an emphasis on precision medicine. Its platform combines clinical and molecular data to help physicians make more informed treatment decisions and support life-sciences research. The company provides genomic sequencing and other diagnostic testing, software tools for analyzing patient data, and services that help identify clinical trial opportunities. Its work spans oncology and other areas of medicine, and it collaborates with healthcare providers and pharmaceutical and biotechnology companies.

Recommended Stories

Want to see what other hedge funds are holding TEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tempus AI, Inc. (NASDAQ:TEM – Free Report).

Institutional Ownership by Quarter for Tempus AI (NASDAQ:TEM)

Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.